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1. Introduction 
A series of morphinomimetic peptides has been 
isolated from brain or pituitary [l-6]. Comparison of 
their abilities to displace specifically bound [?I] - 
naloxone from brain opiate receptors howed that 
C-Fragment (lipotropin 61-9 1) is much more potent 
than C’-Fragment (61-87), rendorphin (61-77), 
ar-endorphin (61-76) or methionine nkepe [7]. 
lnvestigation of the analgesic properties revealed that 
the shorter peptides are at most weakly active whereas 
C-Fragment produces profound and long lasting 
analgesia [8-l 11. In addition, the C-Fragment alone 
exhibits other central activities, including the stimu- 
lation of grooming [12], inhibition of neurotrans- 
mitter release [131 and the production of hyper- 
glycaemia [14]. The high potency of C-Fragment in 
its central actions would seem to imply that this is the 
physiologically significant agent in brain. 
In the present investigation we have shown that the 
proteolytic degradation of C-Fragment in striatal 
slices takes place in a specific manner with the formation 
of products corresponding to the range of opiate 
active peptides that have been isolated from brain. 
2. Materials and methods 
2.1. Iodination of peptides 
C-Fragment and C’-Fragment were isolated from 
porcine pituitary [ 11. Methionine nkephalin and the 
heptapeptide 61-67 were synthesised by Dr A. F. 
Bradbury. 7-Endorphin was obtained by rennin 
digestion of C-Fragment [ 151 and 61-73 by carboxy- 
peptidase A digestion of y-endorphin [171. The 
North-Holland Atblishing Company - Amsterdam 
octadecapeptide 61-78 was prepared by chymotryptic 
digestion of C-Fragment [ 151. The peptides were 
iodinated by the method of Hunter and Greenwood 
[ 161 to give a specific activity of approx. 2 Ci/mrnol. 
Each peptide was purified by gel fdtration on Sephadex 
G-10 (column dimension 2 X 0.2 cm) in 50% (v/v) 
acetic acid. 
2.2. Incubation with stn’atal slices 
Coronal slices (approx. 200 mg wet wt) through 
the corpus striatum were prepared by section of fresh 
rat brains 3.5 mm and 2.5 mm rostral to the anterior 
part of the optic chiasma. The slices were preincubated 
(45 min, 37°C) in 3 ml saline (NaCl134 mM, KC1 5 mM, 
KH2F04 1.25 mM, MgS04 2.0 mM, CaClz 1.0 mM, 
NaHC03 16 mM, glucose 10 mM) containing the 
appropriate bacitracin concentration. The slices were 
transferred and gently agitated at 37’C in 3 ml of 
saline, or 3 ml of saline lO+ M in bacitracin, containing 
6 X lo6 cpm of iodinated peptide. Aliquots (0.3 ml) 
were taken at intervals and an equal volume of glacial 
acetic acid added. Each sample was submitted to gel 
filtiation on Sephadex G-50 (150 X 0.9 cm) in 50% 
(v/v) acetic acid and the eluate fractions were monitored 
for radioactivity. It may be noted that C-Fragment 
behaves anomalously during gel filtration at neutral 
pH; in 50% acetic acid C-Fragment and its related pep 
tides behave reproducibly and are recovered in high 
yield. 
3. Results and discussion 
3.1. &gradation by endogenous aminopep tidase 
The use of iodine-labelled peptides ensured that 
the incubations could be perf&med at approaching 
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physiological concentration (approx. lO_” M); 
products with the amino terminal region intact could 
be readily detected since the only iodinatable residue 
in the peptides is the terminal tyrosine. 
[ 12’ I] C-Fragment on incubation with striatal 
slices was degraded slowly, with a half-life of 3.2 h 
(Fig.1). In the presence of bacitracin, an aminopeptidase 
inhibitor, the half-life was unchanged, which indicates 
that the degradation of C-Fragment isnot initiated by 
the attack of an aminopeptidase. y-Endorphin had a 
half-life of 1 .l h but in the presence of bacitracin the 
half-life was increased to 3.6 h, in agreement with the 
known susceptibility of this peptide to the action of 
aminopeptidase enzymes [171. 
The degradations are mediated by extracellular 
enzymes in the slices and do not involve an active 
uptake system as even after prolonged incubation there 
was no enrichment of labelled peptide in the tissue. The 
results indicate that the extracellular degradations of
C-Fragment in striatum is not initiated by attack of an 
aminopeptidase; as with the proteolysis catalysed by 
brain membranes [ 151 the first step involves attack by 
an endopeptidase. 
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Fig.1. Effect of bacitracin on the metabolism of C-Fragment 
and r-endorphin. [ ‘ZSI]C-Fragment (o and l ) or -r-endorphin 
(a and 4) were incubated in the absence and presence of low4 
M bacitracin respectively. The incubation mixture was examined 
as described in Materials and methods. Intact peptide was calcu- 
lated from the ratio of counts corresponding to degraded pep 
tide to total counts eluted. 
20 30 A0 50 
Fractlm No. 
Fig.2. Gel filtration of [‘ZSI]C-Fragment after incubation with striatal slices in the presence of 1Om4 M bacitracin. An 0.3 ml aliquot 
taken during incubation at 4 h was diluted with an equal volume of glacial acetic acid and fdtration was performed on Sephadex GSO 
(150 X 0.9 cm) in 50% (v/v) acetic acid, fraction size 2.2 ml. The radioactivity in each fraction was measured in a well-type ycounter. 
The arrows indicate the elution positions of the authentic iodine labelled peptides. 
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3.2. Degradation by endogenous endopeptidases 
The degradation of C-Fragment by endopeptidases 
was readily followed by gel filtration on Sephadex G-50 
(fig.2). The disappearance of C-Fragment was accom- 
panied by the appearance of tyrosine and two peaks 
(A and B) due to intermediate peptides containing the 
intact NH&erminal region. The tyrosine must arise 
from the action of an aminopeptidase onthe interme- 
diate peptides as C-Fragment isresistant under these 
conditions. The addition of bacitracin enhanced the 
formation of the peptides in Fraction A at the 
expense of tyrosine. In the absence of bacitracin, the 
maximum level of the intermediate peptides was 
approx. 10%. Fraction A was rechromatographed on 
SP-Sephadex C-25 (fig. 3) and found to elute with 
authentic [“‘1 17 endorphin; a minor component 
eluted in the position of cr-endorphin. It is not known 
whether o-endorphin is formed directly from 
C-Fragment by the action of an endopeptidase or
whether it arises by loss of the COOH-terminal mino 
acid from -y-endorphin by the action of a carboxy- 
peptidase. Peak B (fig.2) which contains peptides 
shorter than the endorphins, was subjected to further 
chromatography. The principal product was methionine 
enkephalin and there was also a small amount of hexa- 
or heptapeptide (fig.4). It is apparent that the smaller 
peptides are formed only slowly as the yield of meth- 
ionine enkephalin was not greatly increased by the 
presence of 5 X 10s3 M bacitracin. 
The degradation of C-Fragment in striatal slices 
leads to the formation of yendorphin, o-endorphin 
and methionine nkephalin as specific intermediates. 
The extent to which these peptides are formed in vivo 
will depend on the relative distribution of the degrading 
enzymes. It remains to be seen whether the endorphins 
and enkephalin also occur intracellularly as part of a 
neurotransmitter system but the evidence of the present 
experiments i that these peptides can be generated 
extracellularly. It may be that the endorphins and 
enkephalin are not elaborated to perform a specific 
physiological function but represent degradation 
products of the potent opiate active peptide C-Fragment. 
Fig.3. Identification of ~endorphin as the first degradation 
product formed from C-Fragment in strlatal slices. The 
peptide fraction Peak I, obtained by gel filtration of 
[“‘I]~-Fragment incubated with striatal slice in the presence 
of bacitracin, was evaporated in vacua and chromatographed 
with authentic [ ls* I] r-endorphin on SP Sephadex C-25 in 
0.05 M phosphate, pH 4.5, with a linear gradient from O-O.5 
M NaCl(2OOml mixer). The elution position of the 61-73, 
61-76 and 61-78 peptides were established by chromate 
graphy of standard mixtures containing these peptides labelled 
with either ISa1 or ‘“II. 
Fmction NO. 
Fig.4. Identification of methionine enkephalin as the principal 
component of the small peptide fraction formed by degradation 
of C-Fragment in striatal slices. The peptide fraction Peak II, 
obtained by gel fdtration of [ la5 I] C-Fragment on Sephadex 
G-SO, incubated with a striatal slice in the presence of bacitracin, 
was evaporated in vacua and chromatographed on Sephadex 
G15 (150 X 0.9 cm) in 50% (v/v) acetic acid, fraction size 
1.4 ml. The column was calibrated with [ “’ I] C-Fragment, 
the heptapeptide 61-67 and methionine enkephalin (61-65). 
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